Aurora Cannabis Inc. (NYSE:ACB) traded at $9.1 at last check on Tuesday, Sep 01, making a downturn move of -2.1% on its previous days price.
Looking at the stock we see that its previous close was $9.3 and the beta (5Y monthly) reads 0 with the days price range being $8.93 – 9.36. The company has a 12-month trailing PE ratio of 43.06. In terms of its 52-week price range, ACB has a high of $78 and a low of $5.3. The companys stock has gained about -10.75% over that past 30 days.
There have been no upward or downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ACB stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Based on estimates by 19 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 12 have rated the Aurora Cannabis Inc. (ACB) stock as a Hold, while 3 rate it as a Buy. 1 analysts rate it as outperform while none of them rated it as underperform, whereas 3 suggests the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the ACB stock currently stands at 0, and the current price level is -8.04% off its SMA20 and -17.51% from its 50-day simple moving average. The RSI (14) is pointing at 34.61 while the volatility over the past week is 4.8% and drops to 4.76% over the past one month. The beta value is 0, while the average true range (ATR) is currently pointing at 0.52. The average price target for the stock over the next 12 months is $12.67, with the estimates having a low of $7.7 and a high of $21.4. These price ends are -15.38% and +135.16% off the current price level respectively, although investors could be excited at the prospect of a +43.63% if the ACB share price touches on the median price of $13.07.
Lets briefly compare Aurora (ACB) stock to its peers. We find that todays price change of -2.1% and -86.33% over the past 12 months for ACB competes that of Abbott Laboratories (ABT), which has seen its stock price rise 1.46% in the latest trading session and is +26.75% over the last one year. Another of its peers Medtronic Inc (MDT) has climbed 0.6% today, and is +0.05% up over the past year, while Stryker Corp (SYK) is also down -2.1% yet its price remains in the red at -86.33% over the same period. Abbott has a P/E ratio of 61.63 compared to Auroras 43.06 and Medtronics 30.75. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.54% and 0.59%, respectively, in early deals.
Coming back to Aurora Cannabis Inc. (NYSE:ACB), we note that the average 3-month trading volume was 3.77 Million, while that of the preceding 10-day period stands at 2.37 Million. Current shares outstanding are 112.57 Million.
According to data from Thomson Reuters, insiders hold 2.9% of the companys shares while institutions hold 12.27%. The data shows that short shares as of August 13, 2020, stood at 17.52 Million at a short ratio of 5.53. This represents a 15.56% Short interest in Shares outstanding on August 13, 2020. Shares short rose in August from the previous month at 14.45 Million. Investors should be excited about this stock as its upside potential is great, with todays price pushing the stock -64.12% down in year-to-date price movement.
